541Wire StoriesGlobal Plastic Contract Manufacturing Market Analysis Report 2021: Polypropylene Accounted for Over 34% of the Revenue in 2020 – Forecast to 2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Plastic Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (PP, ABS, PE), by Application (Medical, Automotive, Consumer...
- 773Wire Stories
NCL Corporation Ltd. Announces Upsizing and Pricing of $1,000 Million of Exchangeable Notes
MIAMI, Nov. 16, 2021 (GLOBE NEWSWIRE) — NCL Corporation Ltd. (“NCLC”), a subsidiary of Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (“NCLH”),...
- 607Wire Stories
Norwegian Cruise Line Holdings Ltd. Announces Pricing of 46,858,854 Ordinary Shares
MIAMI, Nov. 16, 2021 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (the “Company”) announced today that it has priced...
- 578Wire Stories
Nabis Holdings Announces Mailing of Supplement to Management Information Circular for Meeting of Noteholders
VANCOUVER, British Columbia, Nov. 16, 2021 (GLOBE NEWSWIRE) — Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) (“Nabis” or the “Company”)...
- 584Wire Stories
SharpLink Gaming and Quintar Join Forces to Produce Immersive, Personalized Sports Betting Experience at Live Sports Events
Companies to Integrate SharpLink’s Cutting Edge C4 Sports Betting Conversion Technology with Quintar’s Innovative Q.reality Augmented Reality Technology MINNEAPOLIS and SANTA CLARA,...
- 659Wire Stories
Zai Lab Announces First Patient Dosed in Greater China in Global Registrational Clinical Trial of Efgartigimod in CIDP
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused,...
- 570Wire Stories
Unwrap a super sweet free spins bonus a Juicy Stakes Casino
Players can enjoy up to 120 Free Games on candy themed pokies Sugar Pop 2 and Super Sweets MELBOURNE, Australia–(BUSINESS WIRE)–Fancy unwrapping...
- 625Wire Stories
Transgene and NEC Announce Positive Preliminary Data From Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine
? Positive initial data generated in the first six patients treated with TG4050 demonstrate the strong potential of this individualized immunotherapy in...
- 548Wire Stories
India e-Pharmacy Markets, 2017-2020 & 2021-2027 by Drug Type, Product Type, Operating Platform, & Business Model – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India E Pharmacy Market, By Drug Type (Prescription Drugs v/s Over the Counter (OTC) Drugs), By Product Type (Chronic Diseases,...
- 1.3KWire Stories
PeptiGrowth Inc. Is Launching A Novel Synthetic Peptide TGF?1 Inhibitor, Following Its First Product HGF Alternative Peptide
TOKYO–(BUSINESS WIRE)–PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo, President: Jiro Sugimoto) has successfully developed a novel peptide called TGF?1 inhibitor (TGF?1 binding peptide) which...
